Chocolate Is Being Recalled Nationwide Due to Contamination—Here's What to Know
Tony's Chocolonely Dark Chocolate Almond Sea Salt and Everything bars are recalled.
These chocolate bars were sold nationwide in the U.S. and Canada.
The recall follows consumer complaints of finding small stones in the product.There's an active recall on two types of chocolate bars sold across the U.S. and Canada, according to the Food and Drug Administration. This is due to a foreign matter contamination.
The brand impacted by this recall is Tony's Chocolonely, and the company is recalling its Dark Chocolate Almond Sea Salt and Everything Bar flavors. The 6.35-ounce recalled chocolate bars contain the following information printed on their packaging:
Tony's Chocolonely Dark Chocolate Almond Sea Salt: lot code 4327, 4330, 4331 or M4331, best-by date November 25, 2026, and UPC 850011828564 or 850032676441.
Tony's Chocolonely Everything Bar: lot code 163094, 162634 or M162634, best-by date February 28, 2026 or April 2, 2026, and UPC 858010005641 or 850011828908.
Related: Trader Joe's Just Recalled a Popular Salad Dressing—Here's What to Know
Check your chocolate bars for this recall information, and if you have a recalled product on hand, dispose of it or return it to your place of purchase for a refund. The recall follows 12 consumer complaints of finding small stones in the chocolate, which the company explains is from being 'not filtered during third-party almond harvesting and the almond processing process.'
If you are experiencing any illness or injury after eating the recalled chocolate, consult with your doctor immediately. For questions about this recall, contact Tony's Chocolonely USA at 1-503-388-5990.
Related: Over 210,000 Pounds of Liquid Egg Products Recalled Due to Contamination
Read the original article on EATINGWELL
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNBC
41 minutes ago
- CNBC
FDA approves first-ever glucose monitoring system for weight loss from Signos
The Food and Drug Administration on Wednesday approved the first-ever glucose monitoring system specifically for weight loss from the startup Signos, establishing a new option for Americans to manage their weight. Current treatment options for losing weight – popular drugs like GLP-1s and surgical interventions – are typically limited to patients with obesity or a certain BMI. Obesity drugs such as Novo Nordisk's Wegovy and Eli Lilly's Zepbound can also be difficult to access due to their high costs, limited U.S. insurance coverage and constrained supply. But now, any patient can purchase a Signos membership to access its system. It uses an AI platform and an off-the-shelf continuous glucose monitor, or CGM, from Dexcom to offer personalized, real-time data and lifestyle recommendations for weight management. "There is now a solution that everybody can use to help on the weight loss journey, and you don't have to be a certain number of pounds to use it. It's available for the average American who needs it," said Sharam Fouladgar-Mercer, Signos' co-founder and CEO, in an interview on Tuesday ahead of the approval. "The average person might have five pounds to lose, or others might have 100 pounds to lose. We are here to help them at any point in that journey." The obesity epidemic costs the U.S. health-care system more than $170 billion a year, according to Centers for Disease Control and Prevention data. Almost 74% of Americans are overweight or obese, government data says. Signos hopes it can make a "real big dent in that curve for the betterment of many of us," Fouladgar-Mercer said. Customers who sign up for Signos can choose a three-month or six-month plan, which currently costs $139 and $129, respectively. The company will ship out all of the CGMs a patient needs for the number of months in the plan they choose. Insurers currently don't cover the system for weight management, but the plans are a fraction of the roughly $1,000 monthly price of GLP-1s in the U.S. Signos is working with health insurance companies and employers to get coverage for the system, the company said in a statement to CNBC. Signos said it expects "this to evolve quickly as interest for tackling weight continued to expand." The Signos system can be used in combination with GLP-1s or bariatric surgery, said Fouladgar-Mercer. He said patients can also use the system after getting off a GLP-1 to maintain their weight loss. CGMs are small sensors worn on the upper arm that track glucose levels, mainly for people with diabetes. That data is wirelessly sent to Signos' app, which also allows patients to log their food intake and exercise levels, among other information that the AI platform uses to make recommendations. Apart from helping people lose pounds, the system aims to help users understand how their bodies respond to specific foods and exercise patterns and make the right behavioral changes to manage and maintain their weight in the long term. Signos did not share how many patients are currently using its glucose monitoring system, but Fouladgar-Mercer said tens of thousands of people have already tried it over time. He said Signos has scaled up its CGM inventory and software capacity to "handle a pretty massive scale" following the approval.
American Military News
7 hours ago
- American Military News
Gov't agency exposed for allowing drugs from dangerous foreign factories into the US: Report
A new report claims that the U.S. Food and Drug Administration secretly allowed substandard foreign factories with dangerous manufacturing issues to ship hundreds of medications to the United States despite being officially banned by the agency. In June, ProPublica reported that a group of individuals inside the Food and Drug Administration exempted drugs shipped to the U.S. from foreign factories despite the agency banning imports from certain factories due to contamination and other issues. The outlet noted that pills and other medications exempted from the bans were distributed to Americans and claimed that the agency did not regularly test the drugs for quality issues or track the medications to determine whether the medications were causing harm. According to ProPublica, Janet Woodcock, a former Food and Drug Administration employee, told the outlet, 'We felt we didn't have to make it a public thing.' READ MORE: Experimental vaccine may prevent recurrence of cancer In a new report, ProPublica claimed that the Food and Drug Administration did not adequately monitor various reports filed by medical providers and other individuals who warned that some drugs had a bad odor, residue, or abnormal taste. The outlet claimed that the government agency also did not adequately monitor reports of patients experiencing abnormal health issues potentially related to certain medications. According to ProPublica, the Food and Drug Administration largely withheld the information regarding the medication import ban exemptions from the American public and has not shared a list of medications that the U.S. government allowed into the country from foreign factories banned by the agency. However, ProPublica released a list of the drugs and ingredients that the outlet determined were exempted from import bans since 2013. The list also reveals the manufacturing companies responsible for the production of the medications. ProPublica reported that the news outlet found that the Food and Drug Administration exempted over 150 medications and ingredients from import bans. While the majority of the exempted products came from India, ProPublica reported that a Chinese factory and a Hungarian factory were also exempted by the federal agency.
Axios
7 hours ago
- Axios
Potentially radioactive shrimp recalled at Walmarts in a dozen states
The Food and Drug Administration warned Tuesday against eating certain brands of shrimp because they might be, uh, radioactive. Why it matters: This is not your chance to develop amazing crustacean-based superpowers. Any prolonged exposure to radiation could cause sickness or even death. Driving the news: The FDA said Tuesday that certain types of Great Value raw frozen shrimp sold at Walmart may be contaminated with Cesium-137, a radioactive isotope. U.S. Customs and Border Protection initially told the FDA that Cesium-137 had been detected in containers at four different U.S. ports, the FDA said. The FDA then found the isotope in one sample of breaded shrimp. Indonesia's BMS Foods allegedly violated the Federal Food, Drug, and Cosmetic Act, the FDA said, because the product "appears to have been prepared, packed, or held under insanitary conditions whereby it may have become contaminated with Cs-137 and may pose a safety concern." Yes, but: No shrimp that tested positive for the radioactive isotope have entered the U.S. commerce supply, according to the FDA. All products from BMS are banned "from coming into the U.S. until the firm has resolved the conditions that gave rise to the appearance of the violation," the FDA said. Worth noting: The FDA oversees safety of both domestic and imported seafood. The agency seeks out any immediate or potential threats when assessing products for safety. Which Walmart shrimp products are radioactive? Zoom in: The FDA shared three Great Value products that should not be shared, eaten or served to others: Great Value brand frozen raw shrimp, lot code: 8005540-1, Best by Date: March 15, 2027 Great Value brand frozen raw shrimp, lot code: 8005538-1, Best by Date: March 15, 2027 Great Value brand frozen raw shrimp, lot code: 8005539-1, Best by Date: March 15, 2027 Context: These were sold at stores in Alabama, Arkansas, Florida, Georgia, Kentucky, Louisiana, Missouri, Mississippi, Ohio, Oklahoma, Pennsylvania, Texas and West Virginia, according to the FDA. Walmart told Axios in an email Tuesday that it recalled the product from impacted stores and customers who purchased the shrimp are eligible for a full refund. "The health and safety of our customers is always a top priority," Kelly Hellbusch, a Walmart spokesperson, said in a statement. "We have issued a sales restriction and removed this product from our impacted stores. We are working with the supplier to investigate." Symptoms of radiation from shrimp, Cesium-137 The FDA said the amount of Cesium-137 found in the shipment was low enough that it "would not pose an acute hazard to consumers." However, the warning "is a measure intended to reduce exposure to low-level radiation that could have health impacts with continued exposure over a long period of time," the FDA said. According to the Environmental Protection Agency, ingesting Cesium-137 can increase the risk of cancer. What to do with recalled Walmart shrimp
